US2010004334A1PendingUtilityA1

Nutritional Compositions Containing Punicalagins

56
Assignee: MEAD JOHNSON NUTRITION COPriority: Jul 1, 2008Filed: May 26, 2009Published: Jan 7, 2010
Est. expiryJul 1, 2028(~2 yrs left)· nominal 20-yr term from priority
Inventors:Zeina JouniDeshanie RaiNagendra Rangavajla
A61P 37/04A61P 37/02A61P 37/08A61P 37/00A61P 29/00A61P 3/02A61P 31/00A61P 17/00A23L 33/105A23V 2002/00A61K 36/73A61K 31/7048A61K 36/185A61K 31/202A23L 33/40
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates generally to a nutritional composition comprising punicalagins.

Claims

exact text as granted — not AI-modified
1 . A nutritional composition comprising:
 a. a protein source;   b. a fat source;   c. a carbohydrate source; and   d. punicalagins.   
   
   
       2 . The nutritional composition according to  claim 1  wherein the amount of punicalagins in the composition is between about 0.004 to about 0.20 mg/g of the composition. 
   
   
       3 . The nutritional composition according to  claim 1 , further comprising punicic acid. 
   
   
       4 . The nutritional composition according to  claim 3 , wherein the amount of punicic acid in the composition is between about 0.01 to about 40 mg/g of the composition. 
   
   
       5 . The nutritional composition according to  claim 1 , further comprising pomegranate leaf extract. 
   
   
       6 . The nutritional composition according to  claim 5 , wherein the amount of pomegranate leaf extract in the composition is between about 4 mg/g to about 60 mg/g of the composition. 
   
   
       7 . The nutritional composition according to  claim 1 , further comprising punicic acid and pomegranate leaf extract. 
   
   
       8 . The nutritional composition according to  claim 1 , wherein the nutritional composition is an infant formula. 
   
   
       9 . A method of enhancing the immune system of a pediatric subject comprising administering punicalagins to the pediatric subject. 
   
   
       10 . The method of  claim 9 , wherein the enhanced immune system function comprises an improved resistance to infection. 
   
   
       11 . The method according to  claim 9 , wherein the amount of punicalagins administered to the pediatric subject is between about 1 mg to about 100 mg per day. 
   
   
       12 . The method according to  claim 9 , wherein the method further comprises administering punicic acid to the pediatric subject. 
   
   
       13 . The method according to  claim 12 , wherein the amount of punicic acid administered to the pediatric subject is between about 50 mg to about 5 g per day. 
   
   
       14 . The method according to  claim 9 , wherein the method further comprises administering pomegranate leaf extract to the pediatric subject. 
   
   
       15 . The method according to  claim 14 , wherein the amount of pomegranate leaf extract administered to the pediatric subject is between about 1 g to about 15 g per day. 
   
   
       16 . The method according to  claim 9 , wherein the method further comprises administering punicic acid and pomegranate leaf extract to the pediatric subject. 
   
   
       17 . A method for reducing allergic inflammatory responses in a pediatric subject comprising administering punicalagins to the pediatric subject. 
   
   
       18 . The method according to  claim 17 , wherein the amount of punicalagins administered to the pediatric subject is between about 1 mg to about 100 mg per day. 
   
   
       19 . The method according to  claim 17 , wherein the method further comprises administering punicic acid to the pediatric subject. 
   
   
       20 . The method according to  claim 17 , wherein the method further comprises administering pomegranate leaf extract to the pediatric subject.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.